AstraZeneca buys partner Omniose for bacterial vaccine technology
AstraZeneca has acquired St. Louis-based biotech Omniose to add its proprietary bioconjugation platform to the company's infectious disease vaccine pipeline.
7 trends tracked about this subject — the full history, oldest to newest below.
AstraZeneca has acquired St. Louis-based biotech Omniose to add its proprietary bioconjugation platform to the company's infectious disease vaccine pipeline.
Research reveals Candida auris copies its entire genome to evade antifungal treatments as cases more than double.
New research indicates that approximately 1 in 8 cancer cases worldwide are tied to infections, highlighting the critical role of preventative vaccines.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Public health reports indicate rising West Nile virus activity with new human cases confirmed across California.
Global sporting events now double as public health stress tests as infectious threats converge with mass gatherings
Public health officials are intensifying surveillance as the 2026 FIFA World Cup prompts concerns regarding the potential international spread of infectious disease.